Caimi PF, Ai WZ, Alderuccio JP, Ardeshna KM, et al. Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase 2 LOTIS-2 study. Haematologica 2023 Aug 31. doi: 10.3324/haematol.2023.283459.
PMID: 37646659